Abstract

BackgroundThe approach for veno-arterial extracorporeal membrane oxygenation implantation (VA-ECMO) in patients with cardiogenic shock can be either surgical or percutaneous. Complete angio-guided percutaneous implantation and explantation could decrease vascular complications. We sought to describe the initial results of complete percutaneous angio-guided ECMO implantation and explantation using preclosing.MethodsAll consecutive patients who underwent peripheral femoro-femoral VA-ECMO percutaneous implantation for refractory cardiogenic shock or cardiac arrest were enrolled in a prospective registry (03/2018–12/2020). Percutaneous preclosing using two closing devices (Perclose ProGlide, Abbott) inserted before cannulation was used in both femoral artery and vein. Explantation was performed using a crossover technique under angiographic guidance. The occurrence of vascular complication was recorded.ResultsAmong the 56 patients who underwent percutaneous VA-ECMO implantation for cardiogenic shock or refractory cardiac arrest, 41 underwent preclosing. Femoral vessel cannulation was successful in all patients and total cannulation time was 20 (10–40) min. Weaning from ECMO was possible in 22/41 patients (54%) and 12 (29%) patients were alive at day 30. Significant vascular complications occurred in 2/41 patients. Percutaneous decannulation was performed in 20 patients with 19/20 technical success rate. All femoral arteries and veins were properly closed using the pre-closing devices without bleeding on the angiographic control except for one patient in whom surgical closure of the artery was required. No patient required transfusion for access related significant bleeding and no other vascular complication occurred. Furthermore, no groin infection was observed after full percutaneous implantation and removal of ECMO.ConclusionEmergent complete percutaneous angio-guided VA-ECMO implantation and explantation using pre-closing technique can be an attractive strategy in patients referred for refractory cardiogenic shock.

Highlights

  • Cardiogenic shock is a dramatic complication of both ischemic and non-ischemic heart failure

  • Emergent complete percutaneous angio-guided veno-arterial extracorporeal membrane oxygenation implantation (VA-ECMO) implantation and explantation using preclosing technique can be an attractive strategy in patients referred for refractory cardiogenic shock

  • Population Between March 2018 and December 2020, 56 patients were treated with percutaneous VA-ECMO in the cardiac catheterization laboratory for refractory cardiogenic shock or cardiac arrest

Read more

Summary

Introduction

Cardiogenic shock is a dramatic complication of both ischemic and non-ischemic heart failure. The initial treatment relies on inotropic therapy to increase the cardiac output [4,5,6] This treatment will fail in a non-negligible number of patients, leading to refractory cardiogenic shock. Venoarterial extracorporeal membrane oxygenation (VAECMO) has been described as an attractive strategy for the support of cardiogenic shock and for the support of cardiac arrest [7,8,9]. It can be implanted trough surgical or percutaneous approach [10, 11]. We sought to describe the initial results of complete percutaneous angio-guided ECMO implantation and explantation using preclosing

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call